Dashboard
Manage Tickers

TELA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 17:06:05

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/11/2025 21:06:28

tela-bio-affirms-fy2025-sales-guidance-of-85000m-88000m-vs-86060m-est
TELA Bio Affirms FY2025 Sales Guidance of ...
08/11/2025 20:49:32

TELA Bio (NASDAQ:TELA) affirms FY2025 sales outlook from $85.000 million-$88.000 million to $85.000 million-$88.000 million vs ...

tela-bio-q2-eps-022-misses-018-estimate-sales-20197m-miss-20680m-estimate
TELA Bio Q2 EPS $(0.22) Misses $(0.18) Est...
08/11/2025 20:03:40

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.18) by...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/09/2025 21:06:01

tela-bio-announces-european-commercial-launch-of-ovitex-inguinal-reinforced-tissue-matrix
TELA Bio Announces European Commercial Lau...
06/03/2025 20:15:52

tela-bio-appoints-jeffrey-blizard-as-president-effective-immediately
TELA Bio Appoints Jeffrey Blizard As Presi...
06/02/2025 12:32:40

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/20/2025 17:05:51

tela-bio-affirms-fy2025-sales-guidance-of-8500m-8800m-vs-8554m-est
TELA Bio Affirms FY2025 Sales Guidance of ...
05/08/2025 20:29:12

TELA Bio (NASDAQ:TELA) affirms FY2025 sales outlook from $85.00 million-$88.00 million to $85.00 million-$88.00 million vs $85....

tela-bio-q1-eps-025-misses-023-estimate-sales-1852m-beat-1736m-estimate
TELA Bio Q1 EPS $(0.25) Misses $(0.23) Est...
05/08/2025 20:28:39

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by...

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

tela-bio-launches-larger-surgical-mesh-to-simplify-complex-reconstructive-procedures
TELA Bio Launches Larger Surgical Mesh to ...
03/31/2025 11:20:36

TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on advancing soft-tissue reconstruction sol...

canaccord-genuity-maintains-buy-on-tela-bio-lowers-price-target-to-7
Canaccord Genuity Maintains Buy on TELA Bi...
03/21/2025 17:23:12

Canaccord Genuity analyst Caitlin Cronin maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $12 to...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/21/2025 17:05:38

citizens-capital-markets-maintains-market-outperform-on-tela-bio-lowers-price-target-to-7
Citizens Capital Markets Maintains Market ...
03/21/2025 16:20:10

Citizens Capital Markets analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the pric...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/21/2025 12:10:22

piper-sandler-downgrades-tela-bio-to-neutral-lowers-price-target-to-2
Piper Sandler Downgrades TELA Bio to Neutr...
03/21/2025 09:55:22

Piper Sandler analyst Matt O'Brien downgrades TELA Bio (NASDAQ:TELA) from Overweight to Neutral and lowers the price tar...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
03/20/2025 21:06:20

tela-bio-q4-2024-gaap-eps-023-misses-022-estimate-sales-17649m-miss-23166m-estimate
TELA Bio Q4 2024 GAAP EPS $(0.23) Misses $...
03/20/2025 20:13:57

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION